Effect of brimonidine tartrate ophthalmic solution 0.2% on pupil size in normal eyes under different luminance conditions

Journal of Cataract and Refractive Surgery

Volumn 27, Issue 4, 2001, Pages 560-564

  McDonald II, James Edward ^a   El Moatassem Kotb, Ahmed M ^b   Decker, Bobby B ^b  

^a McDonald Eye Associates   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BRIMONIDINE; ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; EYE DROPS; QUINOXALINE DERIVATIVE;

ADULT; ARTICLE; CONTROLLED STUDY; DIPLOPIA; DISEASE ASSOCIATION; EYE REFRACTION; FEMALE; HUMAN; HUMAN EXPERIMENT; LUMINANCE; MALE; MEASUREMENT; MIOSIS; NIGHT VISION; NORMAL HUMAN; PHOTOPIC VISION; POSTOPERATIVE COMPLICATION; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PUPIL; PUPILLOMETER; REFRACTION ERROR; VISUAL IMPAIRMENT; CHEMICALLY INDUCED DISORDER; DRUG EFFECT; ILLUMINATION; MIDDLE AGED; PUPIL REFLEX; VISUAL DISORDER;

ADRENERGIC ALPHA-AGONISTS; ADULT; FEMALE; HUMANS; LIGHTING; MALE; MIDDLE AGED; MIOSIS; OPHTHALMIC SOLUTIONS; PUPIL; QUINOXALINES; REFLEX, PUPILLARY; VISION DISORDERS;

EID: 0035319738     PISSN: 08863350     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0886-3350(01)00769-6     Document Type: Article

References (11)

1. Martinez CE, Applegate RA, Klyce SD, et al. Effect of pupillary dilation on corneal optical aberrations after photorefractive keratectomy. Arch Ophthalmol 1998; 116:1053-1062
2. Schlote T, Kriegerowski M, Bende T, et al. Mesopic vision in myopia corrected by photorefractive keratectomy, soft contact lenses, and spectacles. J Cataract Refract Surg 1997; 23:718-725
3. Schumer DJ, Bains HS, Brown KL. Dark-adapted pupil sizes in a prospective evaluation of laser in situ keratomileusis patients. J Cataract Refract Surg 2000; 16:239-241
4. Kohnen T. The importance of reporting the complications of refractive surgery (editorial). J Cataract Refract Surg 1999; 25:1
5. LeBlanc RP. Twelve-month results of an ongoing randomized trial comparing brimonidine tartrate 0.2% and timolol 0.5% given twice daily in patients with glaucoma or ocular hypertension. Ophthalmology 1998; 105:1960-1967
6. Hersh PS, Brint SF, Maloney RK, et al. Photorefractive keratectomy versus laser in situ keratomileusis for moderate to high myopia; a randomized prospective study. Ophthalmology 1998; 105:1512-1522; discussion by JH Talamo, 1522-1523
7. Robin AL. Short-term effects of unilateral 1% apraclonidine therapy. Arch Ophthalmol 1988; 106:912-915
8. Stewart WC, Laibovitz R, Horwitz B, et al. A 90-day study of the efficacy and side effects of 0.25% and 0.5% apraclonidine vs 0.5% timolol. Arch Ophthalmol 1996; 114:938-942
9. Jampel HD, Robin AL, Quigley HA, Pollack IP. Apraclonidine; a one-week dose-response study. Arch Ophthalmol 1988; 106:1069-1073
10. Derick RJ, Robin AL, Walters TR, et al. brimonidine tartrate; a one-month dose response study. Ophthalmology 1997; 104:131-136
11. Mastropasqua L, Carpineto P, Ciancaglini M. Brimonidine and pupillary diameter (letter). Ophthalmology 1998; 105:1352